Fang, T., Pan, X., Huang, J., Chen, J., Song, S., & Zhan, Q. (2022). Heparin therapy in COVID-19: Call for randomized controlled trials (RCTs). BioScience Trends, 16(4), 307. https://doi.org/10.5582/bst.2022.01225
Chicago Style (17th ed.) CitationFang, Tingting, Xianyang Pan, Ju Huang, Jun Chen, Shuli Song, and Qilin Zhan. "Heparin Therapy in COVID-19: Call for Randomized Controlled Trials (RCTs)." BioScience Trends 16, no. 4 (2022): 307. https://doi.org/10.5582/bst.2022.01225.
MLA (9th ed.) CitationFang, Tingting, et al. "Heparin Therapy in COVID-19: Call for Randomized Controlled Trials (RCTs)." BioScience Trends, vol. 16, no. 4, 2022, p. 307, https://doi.org/10.5582/bst.2022.01225.
Warning: These citations may not always be 100% accurate.